≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Psoriatic arthropathies, strict definition

PheWeb

M13_PSORIARTH_STRICT

No definition available.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector
diagram bullet

Check conditions

M13_PSORIARTH_ICD10

3160

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 M07.1*, M07.1*L40.5, M07.2*, M07.2*L40.5, M07.3*, M07.3*L40.5

1 out of 7 registries used, show all original rules.

5

diagram downward connector

Check minimum number of events None

5

diagram downward connector

Include endpoints None

5

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

5

diagram downward connector
M13_PSORIARTH_STRICT

Control definitions

Control conditions not M13_PSORIARTH_ICD10

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF3

Not enough data for upset plot.

Or the full data table

Similar endpoints

↥

List of similar endpoints to Psoriatic arthropathies, strict definition based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

None

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 5 - -
Unadjusted prevalence (%) 0.00 - -
Mean age at first event (years) 38.91 - -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: M13_PSORIARTH_STRICT – Psoriatic arthropathies, strict definition
GWS hits:

Survival analyses between endpoints

↥

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Psoriatic arthropathies, strict definition

↥

Endpoint not on priority list, no data to show.